Abiopharma

🔍 Harkins William Wayne II (Executive)

Company: ROLLINS INC (ROL)

Report Date: 2026-02-20

Detailed Transactions and Holdings:

• Acquired 6,112 shares of Common Stock (Direct)
  Date: 2026-02-20 | Code: A | equity_swap_involved: 0 | shares_owned_after: 20,368.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 357 shares of Common Stock at $53.49 per share (Direct)
  Date: 2026-04-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 20,011.00 | transaction_form_type: 4 | Footnotes: F3, F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-02-20 | Code: H | nature_of_ownership: By: 401(k) | shares_owned_after: 216.00

Footnotes:

• F1: Represents restricted shares issued pursuant to the Issuer's 2018 Stock Incentive Plan that will vest over a three-year period beginning on February 20, 2027, with one-third of the award vesting on that date and the remaining two-thirds vesting in equal portions on each subsequent anniversary of that date. This filing is late due to an administrative error and not any error of the reporting person.
• F2: The amount reported in this column includes restricted shares and unrestricted shares held by the reporting person as of the date of the report.
• F3: The disposition reported on this Form 4 represents shares withheld by the Company to cover tax withholding obligations in connection with the vesting of restricted stock. This filing is late due to an administrative error and not any error of the reporting person.